Download PDF
Thromb Haemost 1996; 76(05): 633-639
DOI: 10.1055/s-0038-1650636
Review Article
Schattauer GmbH Stuttgart

Snake Venom Proteins Modulating the Interaction between von Willebrand Factor and Platelet Glycoprotein lb

Yoshihiro Fujimura
1   The Department of Blood Transfusion, Nara Medical University, Kashihara, Nara, Japan
,
Tomihisa Kawasaki
2   Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd., Tsukuba, Ibaraki, Japan
,
Koiti Titani
3   Institute of Comprehensive Medical Science, Fujita Health University School of Medicine, Toyoake, Aichi, Japan
› Author Affiliations
Further Information

Publication History

Received 08 January 1996

Accepted after resubmission 25 July 1996

Publication Date:
11 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Girma JP, Meyer D, Verweij CL, Pannekoek H, Sixma JJ. Structure-func-tion relationship of human von Willebrand factor. Blood 1987; 70: 605-611
    PubMedGoogle Scholar
  • 2 Sadler JE. von Willebrand factor. J Biol Chem 1991; 266: 18172-18178
    PubMedGoogle Scholar
  • 3 Fujimura Y, Titani K. Structure and function of von Willebrand factor. In: Haemostsis and Thrombosis, 3rd edn Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD. (eds) Churchill Livingstone, London: 379-395 1993
  • 4 Howard MA, Firkin BG. Ristocetin - a new tool in the investigation of platelet aggregation. Thromb Diath Haemorrh 1978; 26: 362-369
    PubMedGoogle Scholar
  • 5 Read MS, Shermer RW, Brinkhous KM. Venom coagglutinin: an activator of platelet aggregation dependent on von Willebrand factor. Proc Natl AcadSci USA 1978; 75: 4514-4518
    CrossrefPubMedGoogle Scholar
  • 6 Brinkhous KM, Read MS, Fricke WA, Wagner RH. Botrocetin (venom coagglutinin): reaction with a broad spectrum of multimeric forms of factor VIII macromolecular complex. Proc Natl Acad Sci USA 1983; 80: 1463-1466
    CrossrefPubMedGoogle Scholar
  • 7 Moake JL, Turner NA, Stathopoulos NA, Nolasco L, Heliums JD. Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood 1988; 71: 1366-1374
    PubMedGoogle Scholar
  • 8 Ikeda Y, Handa M, Kamata T, Kawano K, Kawai Y, Watanabe K, Kawa-kami K, Sakai K, Fukuyama M, Itagaki I, Yoshioka A, Ruggeri ZM. Transmembrane calcium influx associated with von Willebrand factor binding to GPIb in the initiation of shear-induced platelet aggregation. Thromb Haemost 1993; 69: 496-502
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Alevriadou BR, Moake JL, Turner NA, Ruggeri ZM, Folie BJ, Phillips MD, Schreiber AB, Hrinda ME, Mclntire LV. Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Wille-brand factor binding to platelets. Blood 1993; 81: 1263-1276
    PubMedGoogle Scholar
  • 10 Savage B, Sadlivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996; 84: 289-297
    CrossrefPubMedGoogle Scholar
  • 11 Kroll MH, Harris TS, Moake JL, Handin RI, Schafer AI. von Willebrand factor binding to GPIb initiates signals for for platelet activation. J Clin Invest 1991; 88: 1568-1573
    CrossrefPubMedGoogle Scholar
  • 12 Ozaki Y, Satoh K, Yatomi Y, Miura S, Fujimura Y, Kume S. Protein tyrosine phosphorylation in human platelets induced by interaction between glycoprotein lb and von Willebrand factor. Biochem Biophys Acta 1995; 1243: 482-488
    CrossrefPubMedGoogle Scholar
  • 13 Handa M, Titani K, Holland LZ, Roberts JR, Ruggeri ZM. The von Willebrand factor-binding domain of platelet membrane glycoprotein lb. Proc Natl Acad Sci USA 1986; 261: 12579-12585
    PubMedGoogle Scholar
  • 14 Titani K, Takio K, Handa M, Ruggeri ZM. Amino acid sequence of the von Willebrand factor-binding domain of platelet membrane glycoprotein lb. Proc Natl Acad Sci USA 1987; 84: 5610-5614
    CrossrefPubMedGoogle Scholar
  • 15 Lopetz JA, Chung DW, Fujikawa K, Hagen FS, Papayannopoulou T, Roth GJ. Cloning of the a chain of human platelet glycoprotein lb: A transmembrane protein with homology to leucine- rich a2- glycoprotein. Proc Natl Acad Sci USA 1987; 84: 5615-5619
    CrossrefPubMedGoogle Scholar
  • 16 Hess D, Schaller J, Rickli EE, Clemetson KJ. Identification to the disulphide bonds in human platelet glycocalicin. Eur J Biochem 1991; 199: 389-393
    CrossrefPubMedGoogle Scholar
  • 17 Cruz MA, Petersen E, Turci SM, Handin RI. Functional analysis of a recombinant glycoprotein Iba polypeptide which inhibits von Willebrand factor binding to the platelet glycoprotein lb- IX complex and to collagen. J Biol Chem 1992; 267: 1303-1309
    PubMedGoogle Scholar
  • 18 Nurden AT. Human platelet membrane glycoproteins. In: Haemostasis and Thrombosis, 3rd edn Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD. (eds) Churchill Livingstone, London: 115-165 1993
  • 19 Read MS, Potter JY, Brinkhous KM. Role of botrocetin in platelet agglutination: Formation of an activated complex of botrocetin and von Wille-brand factor. Blood 1989; 74: 1031-1035
    PubMedGoogle Scholar
  • 20 Andrews RK, Booth WJ, Gorman JJ, Castaldi PA, Bemdt MC. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin- mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex. Biochemistry 1989; 28: 8317-8326
    CrossrefPubMedGoogle Scholar
  • 21 Okumura T, Lombart C, Jamieson GA. Platelet glycocalicin II. Purification and characterization. J Biol Chem 1976; 251: 5950-5955
    PubMedGoogle Scholar
  • 22 Fujimura Y, Titani K, Usami Y, Suzuki M, Oyama R, Matsui T, Fukui H, Sugimoto M, Ruggeri ZM. Isolation and chemical characterization of two structurally and functionally distinct forms of botrocetin, the platelet coagglutinin isolated from the venom of Bothrops jararaca. Biochemistry 1991; 30: 1957-1964
    CrossrefPubMedGoogle Scholar
  • 23 Paine MJI, Desmond HP, Theakston DG, Crampton JM. Purification, cloning, and molecular characterization of a high molecular weight hemorrhagic metalloprotease, jararhagin, from Bothrops jararaca venom. J Biol Chem 1992; 267: 22869-22876
    PubMedGoogle Scholar
  • 24 Usami Y, Fujimura Y, Miura S, Shima H, Yoshioka A, Hirano K, Suzuki M, Titani K. A 28 kDa-protein with disintegrin-like structure (jararhagin-C) purified from Bothrops jararaca venom inhibits collagen- and ADP-induced platelet aggregation. Biochem Biophy Res Commun 1994; 201: 331-339
    CrossrefPubMedGoogle Scholar
  • 25 Usami Y, Fujimura Y, Suzuki M, Ozeki Y, Nishio K, Fukui H, Titani K. Primary structure of two-chain botrocetin; a von Willebrand factor modulator purified from the venom of Bothrops jararaca. Proc Natl Acad Sci USA 1993; 90: 928-932
    CrossrefPubMedGoogle Scholar
  • 26 Drickamer K. Two distinct classes of carbohydrate recognition-domains in animal lectins. J Biol Chem 1988; 263: 9557-9560
    PubMedGoogle Scholar
  • 27 Giga Y, Ikai A, Takahashi K. The complete amino acid sequence of echinoidin, a lectin from the coelomic fluid of the sea urchin Anthocidaris crassispina. J Biol Chem 1987; 262: 6197-6203
    PubMedGoogle Scholar
  • 28 Hirabayashi J, Kusunoki T, Kasai K. Complete primary structure of a galactose-specific lectin from the venom of the Rattlesnake Crotalus atrox. Homologies with Ca2+-dependent-type lectins. J Biol Chem 1991; 266: 2320-2326
    PubMedGoogle Scholar
  • 29 Fujimura Y, Titani K, Holland LZ, Russell SR, Roberts JR, Elder JH, Ruggeri ZM, Zimmerman TS. von Willebrand factor. A reduced and alkylated 52/48 kDa fragment beginning at amino acid residue 449 contains the domains interacting with platelet glycoprotein lb. J Biol Chem 1986; 261: 381-385
    PubMedGoogle Scholar
  • 30 Fujimura Y, Usami Y, Titani K, Niinomi K, Nishio K, Takase T, Yoshioka A, Fukui H. Studies on anti-von Willebrand factor (vWF) monoclonal antibody NMC-4 which inhibits both ristocetin- and botrocetin-induced vWF binding to platelet glycoprotein lb. Blood 1991; 77: 113-120
    PubMedGoogle Scholar
  • 31 Azuma H, Hayashi T, Dent JA, Ruggeri ZM, Ware J. Disulfide bond requirements for assembly of the platelet glycoprotein Ib-binding domain of von Willebrand factor. J Biol Chem 1993; 268: 2821-2827
    PubMedGoogle Scholar
  • 32 Dong Z, Thomas RS, Crimmins DL, McCourt DW, Tuley EA, Sadler JE. Disulfide bonds required to assemble functional von Willebrand factor multimers. J Biol Chem 1994; 269: 6753-6758
    PubMedGoogle Scholar
  • 33 Fujimura Y, Miyata S, Nishida S, Miura S, Kaneda M, Yoshioka A, Fukui H, Katayama M, Tuddenham EGD, Usami Y, Titani K. The interaction of botrocetin with normal or variant von Willebrand factor (types IIA and IIB) and its inhibition by monoclonal antibodies that block receptor binding. Thromb Haemost 1992; 68: 464-469
    Article in Thieme ConnectPubMedGoogle Scholar
  • 34 Sugimoto M, Mohri H, McClintock RA, Ruggeri ZM. Identification of discontinuous von Willebrand factor sequences involved in complex formation with botrocetin: a model for regulation of von Willebrand factor binding to platelet glycoprotein lb. J Biol Chem 1991; 266: 18172-18178
    PubMedGoogle Scholar
  • 35 Sugimoto M, Ricca G, Hrinda ME, Schreiber AB, Searfoss GH, Bottini E, Ruggeri ZM. Functional modulation of the isolated glycoprotein lb binding domain of von Willebrand factor expressed in Escherichia coli. Biochemistry 1991; 30: 5202-5209
    CrossrefPubMedGoogle Scholar
  • 36 Andrews RK, Gorman JJ, Booth WJ, Corino GL, Castaldi PA, Bemdt MC. Cross-linking of a monomeric 39/34-kDa dispase fragment of von Willebrand factor (Leu-480/Val481 - Gly-718) to the N-terminal region of the a-chain of membrane glycoprotein lb on intact platelets with bis (sulfosuc-cinimidyl) suberate. Biochemistry 1989; 28: 8326-8336
    CrossrefPubMedGoogle Scholar
  • 37 Miura S, Fujimura Y, Sugimoto M, Kawasaki Y, Ikeda Y, Titani K, Yoshioka A. Structural elements influencing von Willebrand factor (vWF) affinity for platelet glycoprotein lb within a dispase-digested vWF. Blood 1994; 84: 1553-1558
    PubMedGoogle Scholar
  • 38 Ginsburg D, Sadler JE. von Willebrand disease: a database of point mutations, insertions, and deletions. Thromb Haemost 1993; 69: 177-184
    Article in Thieme ConnectPubMedGoogle Scholar
  • 39 Hilbert L, Gaucher C, de Romeuf C, Horellou MH, Mazurier C. Leu 697->-Val mutation in mature von Willebrand factor is responsible for type IIB von Willebrand disease. Blood 1994; 83: 1542-1550
    PubMedGoogle Scholar
  • 40 Federici AB, Stabile MT, Canciani S, Miyata S, Ware JL. New mutation Ile(546)(Val in a family with type IIB von Willebrand disease characterized by spontaneous platelet aggregation, thrombocytopenia and normal levels of ristocetin cofactor. Thromb Haemost 1995; 73: 1170 (abstract)
    PubMedGoogle Scholar
  • 41 Mohri H, Fujimura Y, Shima M, Yoshioka A, Houghten RA, Ruggeri ZM, Zimmerman TS. Structure of the von Willebrand factor domain interacting with glycoprotein lb. J Biol Chem 1988; 263: 17901-17904
    PubMedGoogle Scholar
  • 42 Bemdt MC, Ward CM, Booth WJ, Castaldi PA, Mazurov AV, Andrews RK. Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence. Mechanisms of modulation of von Willebrand factor by ristocetin and botrocetin. Biochemistry 1992; 31: 11144-11151
    CrossrefPubMedGoogle Scholar
  • 43 Sobel M, Sobel DF, Kermode JC, Harris RB. Localization and characterization of a heparin binding domain peptide of human von Willebrand factor. J Biol Chem 1992; 267: 8857-8862
    PubMedGoogle Scholar
  • 44 Christophe O, Obert B, Meyer D, Girma JP. The binding domain of von Willebrand factor to sulfatides is distinct from those interacting with glycoprotein lb, heparin, and collagen and resides between amino acid residues Leu512 and Lys673. Blood 1991; 78: 2310-2317
    PubMedGoogle Scholar
  • 45 Makita K, Miura S, Shimoyama T, Narita N, Sakurai T, Sugimoto M, Yoshioka A, Titani K, Ruggeri ZM, Fujimura Y. Characterization of murine anti-botrocetin monoclonal antibodies. Int J Haematol 1995; 61: 276 (Abstract)
    PubMedGoogle Scholar
  • 46 Vicente V, Houghten RA, Ruggeri ZM. Identification of a site in the alpha chain of platelet glycoprotein lb that participates in von Willebrand factor binding. J Biol Chem 1990; 265: 274-280
    PubMedGoogle Scholar
  • 47 Katagiri Y, Hayashi Y, Yamamoto K, Tanoue K, Kosaki G, Yamazaki H. Localization of von Willebrand factor and thrombin-interactive domains on human platelet glycoprotein GPIb. Thromb Haemost 1990; 63: 122-126
    Article in Thieme ConnectPubMedGoogle Scholar
  • 48 Dong JF, Li CQ, Lopez JA. Tyrosine sulfation of the glycoprotein Ib-IX complex: identification of sulfated residues and effect on ligand binding. Biochemistry 1994; 33: 13946-13953
    CrossrefPubMedGoogle Scholar
  • 49 Marchese P, Murata M, Mazzucatto M, Pradella P, De Marco L, Ware J, Ruggeri ZM. Identification of three tyrosine residues of glycoprotein lb a with distinct roles in von Willebrand factor and a-thrombin binding. J Biol Chem 1995; 270: 9571-9578
    CrossrefPubMedGoogle Scholar
  • 50 Ward CM, Andrews RK, Smith AI, Berndt MC. Mocarhagin, a novel cobra venom metalloprotease, cleaves the platelet von Willebrand factor receptor glycoprotein lb a. Identification of the sulfated tyrosine/anionic sequence Tyr276-Glu282 of glycoprotein Iba as a binding site for von Willebrand factor and a-thrombin. Biochemistry 1996; 35: 4929-4938
    CrossrefPubMedGoogle Scholar
  • 51 Scarborough RM, Hsu MA, Teng W, Nannizzi L, Rose JW. Purification and characterization of potent inhibitors of von Willebrand factor binding to glycoprotein (GP)Ib from the venom of the timber rattlesnake, Crotalus h. horridus. Blood 1991; 78: 1568 (abstract)
    PubMedGoogle Scholar
  • 52 Peng M, Lu W, Kirby EP. Alboaggregin-B: a new platelet agonist that binds to platelet membrane glycoprotein lb. Biochemistry 1991; 30: 11529-11536
    CrossrefPubMedGoogle Scholar
  • 53 Peng M, Lu W, Kirby EP. Characterization of three alboaggregins purified from Trimeresurus alborablis venom. Thromb Haemost 1992; 67: 702-707
    Article in Thieme ConnectPubMedGoogle Scholar
  • 54 Yoshida E, Fujimura Y, Miura S, Sugimoto M, Fukui H, Narita N, Usami Y, Suzuki M, Titani K. Alboaggregin-B and botrocetin, two snake venom proteins with highly homologous amino acid sequences but totally distinct functions on von Willebrand factor binding to platelets. Biochem Biophy Res Commun 1993; 1386-1392
    PubMedGoogle Scholar
  • 55 Usami Y, Suzuki M, Yoshida E, Sakurai Y, Hirano K, Kawasaki T, Fujimura Y, Titani K. Primary structure of alboaggregin-B purified from the venom of Trimeresurus alborablis. Biochem Biophys Res Comm 1996; 219: 727-733
    CrossrefPubMedGoogle Scholar
  • 56 Peng M, Lu W, Beviglia L, Niewiarowski S, Kirby EP. Echicetin: a snake venom protein that inhibits binding of von Willebrand factor and alboaggregins to platelet glycoprotein lb. Blood 1993; 81: 2321-2328
    PubMedGoogle Scholar
  • 57 Chen YL, Tsai IH. Functional and sequence characterization of agkicetin, a new glycoprotein lb antagonist isolated from Agkistrodon acutus venom. Biochem Biophys Res Commun 1995; 210: 472-477
    CrossrefPubMedGoogle Scholar
  • 58 Peng M, Holt JC, Niewiarowski S. Isolation, characterization and amino acid sequence of echicetin (3 subunit, a specific inhibitor to von Willebrand factor and thrombin interaction with glycoprotein lb. Biochem Biophys Res Commun 1994; 205: 68-72
    CrossrefPubMedGoogle Scholar
  • 59 Fujimura Y, Ikeda Y, Miura S, Yoshida E, Shima H, Nishida S, Suzuki M, Titani K, Taniuchi Y, Kawasaki T. Isolation and characterization of jarara-ca GPIb-BP, a snake venom antagonist specific to platelet glycoprotein lb. Thromb Haemost 1995; 74: 743-750
    Article in Thieme ConnectPubMedGoogle Scholar
  • 60 Taniuchi Y, Kawasaki T, Fujimura Y, Suzuki M, Titani K, Sakai Y, Kaku S, Hisamichi N, Satoh N, Takenaka T, Handa M, Sawai Y. Flavocetin-A and -B, two high molecular mass glycoprotein lb binding proteins with high affinity purified from Trimeresurus flavoviridis venom, inhibit platelet aggregation at high shear stress. Biochem Biophys Acta 1995; 1244: 331-338
    CrossrefPubMedGoogle Scholar
  • 61 Kawasaki T, Taniuchi Y, Hisamichi N, Fujimura Y, Suzuki M, Titani K, Kaku S, Satoh N, Takenaka T, Handa M, Sawai Y. Tokaracetin, a new platelet antagonist that binds to platelet glycoprotein lb and inhibits von Willebrand factor- dependent shear-induced platelet aggregation. Biochem J 1995; 308: 947-953
    CrossrefPubMedGoogle Scholar
  • 62 Kawasaki T, Fujimura Y, Usami Y, Suzuki M, Miura S, Sakurai Y, Makita K, Taniuchi Y, Hirano K, Titani K. Complete amino acid sequence and identification of the platelet glycoprotein lb binding site of jararaca GPIb-BP, a snake venom protein isolated from Bothrops jararaca. J Biol Chem 1996; 271: 10635-10639
    CrossrefPubMedGoogle Scholar